HCW Biologics Inc. (HCWB) Executive Compensation
HCW Biologics Inc. (HCWB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HCWB
CIK: 1828673
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Crowe LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerRonald Melling
Audit LocationIndianapolis, Indiana, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-09 | — | EFFECT Filing | 9999999995-26-003211 | View SEC Doc Filr Page |
| D | 2026-10-08 | — | D Filing | 0001828673-26-000006 | View SEC Doc Filr Page |
| S-1 | 2026-10-02 | — | S-1 | 0001493152-26-045532 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-01 | 2026-10-01 | DEF 14A | 0001493152-26-045289 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-23 | 8-K | 0001493152-26-044078 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-09 | 8-K | 0001493152-26-042009 | View SEC Doc Filr Page |
| PRER14A | 2026-09-09 | — | PRER14A | 0001493152-26-041980 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-04 | 8-K | 0001493152-26-041716 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-08 | 2026-09-04 | PRE 14A | 0001493152-26-041628 | View SEC Doc Filr Page |
| EFFECT | 2026-08-31 | — | EFFECT Filing | 9999999995-26-002836 | View SEC Doc Filr Page |
| S-1/A | 2026-08-28 | — | S-1/A | 0001493152-26-040618 | View SEC Doc Filr Page |
| S-1 | 2026-08-20 | — | S-1 | 0001493152-26-039452 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038262 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001493152-26-038258 | View SEC Doc Filr Page |
| 10-Q/A | 2026-08-14 | 2026-03-31 | 10-Q/A | 0001493152-26-038246 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-10 | 8-K | 0001493152-26-038240 | View SEC Doc Filr Page |
| D | 2026-08-06 | — | D Filing | 0001828673-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | 4 | 0001493152-26-035634 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | 4 | 0001493152-26-035631 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | 4 | 0001493152-26-035619 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001493152-26-035233 | View SEC Doc Filr Page |
| POS AM | 2026-07-16 | — | POS AM | 0001493152-26-033429 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | 8-K | 0001493152-26-031441 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-29 | 8-K | 0001493152-26-031204 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-24 | 8-K | 0001493152-26-030236 | View SEC Doc Filr Page |